Illinois 2023-2024 Regular Session

Illinois House Bill HB2949 Compare Versions

OldNewDifferences
1-Public Act 103-0438
21 HB2949 EnrolledLRB103 27415 DTM 53787 b HB2949 Enrolled LRB103 27415 DTM 53787 b
32 HB2949 Enrolled LRB103 27415 DTM 53787 b
4-AN ACT concerning State government.
5-Be it enacted by the People of the State of Illinois,
6-represented in the General Assembly:
7-Section 5. The Asthma Inhalers at Recreational Camps Act
8-is amended by changing Sections 1, 5, and 10 as follows:
9-(410 ILCS 607/1)
10-Sec. 1. Short title. This Act may be cited as the Emergency
11-Asthma Inhalers and Allergy Treatment for Children at
12-Recreational Camps Act.
13-(Source: P.A. 94-670, eff. 8-23-05.)
14-(410 ILCS 607/5)
15-Sec. 5. Definitions. In this Act:
16-"After-school care program" means an after-school care
17-program operated by a park district or any nonprofit entity.
18-"Recreational camp" means any place set apart for
19-recreational purposes for boys and girls. "Recreational camp"
20-shall not apply to private camps owned or leased for
21-individual or family use, or to any camp operated for a period
22-of less than 10 days in a year.
23-(Source: P.A. 94-670, eff. 8-23-05.)
24-(410 ILCS 607/10)
3+1 AN ACT concerning State government.
4+2 Be it enacted by the People of the State of Illinois,
5+3 represented in the General Assembly:
6+4 Section 5. The Asthma Inhalers at Recreational Camps Act
7+5 is amended by changing Sections 1, 5, and 10 as follows:
8+6 (410 ILCS 607/1)
9+7 Sec. 1. Short title. This Act may be cited as the Emergency
10+8 Asthma Inhalers and Allergy Treatment for Children at
11+9 Recreational Camps Act.
12+10 (Source: P.A. 94-670, eff. 8-23-05.)
13+11 (410 ILCS 607/5)
14+12 Sec. 5. Definitions. In this Act:
15+13 "After-school care program" means an after-school care
16+14 program operated by a park district or any nonprofit entity.
17+15 "Recreational camp" means any place set apart for
18+16 recreational purposes for boys and girls. "Recreational camp"
19+17 shall not apply to private camps owned or leased for
20+18 individual or family use, or to any camp operated for a period
21+19 of less than 10 days in a year.
22+20 (Source: P.A. 94-670, eff. 8-23-05.)
23+21 (410 ILCS 607/10)
2524
2625
2726
2827 HB2949 Enrolled LRB103 27415 DTM 53787 b
2928
3029
31-Sec. 10. Possession, self-administration, and use of
32-epinephrine auto-injectors or inhalers at recreation camps and
33-after-school care programs.
34-(a) A recreation camp or an after-school care program
35-shall permit a child with severe, potentially life-threatening
36-allergies to possess, self-administer, and use an epinephrine
37-auto-injector or inhaler, if the following conditions are
38-satisfied:
39-(1) The child has the written approval of his or her
40-parent or guardian.
41-(2) The recreational camp or after-school care program
42-administrator or, if a nurse is assigned to the camp or
43-program, the nurse shall receive copies of the written
44-approvals required under paragraph (1) of subsection (a)
45-of this Section.
46-(3) The child's parent or guardian shall submit
47-written verification confirming that the child has the
48-knowledge and skills to safely possess, self-administer,
49-and use an epinephrine auto-injector or inhaler in a camp
50-or an after-school care program setting.
51-(b) The child's parent or guardian shall provide the camp
52-or program with the following information:
53-(1) the child's name;
54-(2) the name, route, and dosage of medication;
55-(3) the frequency and time of medication
56-administration or assistance;
30+HB2949 Enrolled- 2 -LRB103 27415 DTM 53787 b HB2949 Enrolled - 2 - LRB103 27415 DTM 53787 b
31+ HB2949 Enrolled - 2 - LRB103 27415 DTM 53787 b
32+1 Sec. 10. Possession, self-administration, and use of
33+2 epinephrine auto-injectors or inhalers at recreation camps and
34+3 after-school care programs.
35+4 (a) A recreation camp or an after-school care program
36+5 shall permit a child with severe, potentially life-threatening
37+6 allergies to possess, self-administer, and use an epinephrine
38+7 auto-injector or inhaler, if the following conditions are
39+8 satisfied:
40+9 (1) The child has the written approval of his or her
41+10 parent or guardian.
42+11 (2) The recreational camp or after-school care program
43+12 administrator or, if a nurse is assigned to the camp or
44+13 program, the nurse shall receive copies of the written
45+14 approvals required under paragraph (1) of subsection (a)
46+15 of this Section.
47+16 (3) The child's parent or guardian shall submit
48+17 written verification confirming that the child has the
49+18 knowledge and skills to safely possess, self-administer,
50+19 and use an epinephrine auto-injector or inhaler in a camp
51+20 or an after-school care program setting.
52+21 (b) The child's parent or guardian shall provide the camp
53+22 or program with the following information:
54+23 (1) the child's name;
55+24 (2) the name, route, and dosage of medication;
56+25 (3) the frequency and time of medication
57+26 administration or assistance;
5758
5859
59-(4) the date of the order;
60-(5) a diagnosis and any other medical conditions
61-requiring medications, if not a violation of
62-confidentiality or if not contrary to the request of the
63-parent or guardian to keep confidential;
64-(6) specific recommendations for administration;
65-(7) any special side effects, contraindications, and
66-adverse reactions to be observed;
67-(8) the name of each required medication; and
68-(9) any severe adverse reactions that may occur to
69-another child, for whom the epinephrine auto-injector or
70-inhaler is not prescribed, should the other child receive
71-a dose of the medication.
72-(c) If the conditions of this Act are satisfied, the child
73-may possess, self-administer, and use an epinephrine
74-auto-injector or inhaler at the camp or after-school care
75-program or at any camp-sponsored or program-sponsored
76-activity, event, or program.
77-(d) The recreational camp or after-school care program
78-must inform the parents or guardians of the child, in writing,
79-that the recreational camp or after-school care program and
80-its employees and agents are to incur no liability, as
81-applicable, except for willful and wanton conduct, as a result
82-of any injury arising from the self-administration of
83-medication to the child. The parents or guardians of the child
84-must sign a statement acknowledging that the recreational camp
8560
8661
87-or after-school care program is to incur no liability, except
88-for willful and wanton conduct, as a result of any injury
89-arising from the self-administration of medication by the
90-child and that the parents or guardians must indemnify and
91-hold harmless the recreational camp or after-school care
92-program and its employees and agents, as applicable, against
93-any claims, except a claim based on willful and wanton
94-conduct, arising out of the self-administration of medication
95-by the child.
96-(e) After-school care program personnel who have completed
97-an anaphylaxis training program as identified under the
98-Epinephrine Injector Act may administer an undesignated
99-epinephrine injection to any child if the after-school care
100-program personnel believe in good faith that the child is
101-having an anaphylactic reaction while in the after-school care
102-program. After-school care program personnel may carry
103-undesignated epinephrine injectors on their person while in
104-the after-school care program.
105-(f) After-school care program personnel may administer
106-undesignated asthma medication to any child if the
107-after-school care program personnel believe in good faith that
108-the child is experiencing respiratory distress while in the
109-after-school care program. After-school care program personnel
110-may carry undesignated asthma medication on their person while
111-in the after-school care program.
112-(g) If after-school care program personnel are to
62+
63+ HB2949 Enrolled - 2 - LRB103 27415 DTM 53787 b
11364
11465
115-administer an undesignated epinephrine injection or an
116-undesignated asthma medication to a child, the after-school
117-care program personnel must inform the parents or guardians of
118-the child, in writing, that the after-school care program and
119-its employees and agents, acting in accordance with standard
120-protocols and the prescription for the injection or
121-medication, shall incur no liability, except for willful and
122-wanton conduct, as a result of any injury arising from the
123-administration of the injection or medication, notwithstanding
124-whether authorization was given by the child's parents or
125-guardians or by the child's physician, physician assistant, or
126-advanced practice registered nurse. A parent or guardian of
127-the child must sign a statement acknowledging that the
128-after-school care program and its employees and agents are to
129-incur no liability, except for willful and wanton conduct, as
130-a result of any injury arising from the administration of the
131-medication or injection, regardless of whether authorization
132-was given by a parent or guardian of the child or by the
133-child's physician, physician assistant, or advanced practice
134-registered nurse, and that the parent or guardian must also
135-indemnify and hold harmless the after-school care program and
136-its employees and agents against any claims, except a claim
137-based on willful and wanton conduct, arising out of the
138-administration of the medication or injection, regardless of
139-whether authorization was given by the child's parent or
140-guardian or by the child's physician, physician assistant, or
66+HB2949 Enrolled- 3 -LRB103 27415 DTM 53787 b HB2949 Enrolled - 3 - LRB103 27415 DTM 53787 b
67+ HB2949 Enrolled - 3 - LRB103 27415 DTM 53787 b
68+1 (4) the date of the order;
69+2 (5) a diagnosis and any other medical conditions
70+3 requiring medications, if not a violation of
71+4 confidentiality or if not contrary to the request of the
72+5 parent or guardian to keep confidential;
73+6 (6) specific recommendations for administration;
74+7 (7) any special side effects, contraindications, and
75+8 adverse reactions to be observed;
76+9 (8) the name of each required medication; and
77+10 (9) any severe adverse reactions that may occur to
78+11 another child, for whom the epinephrine auto-injector or
79+12 inhaler is not prescribed, should the other child receive
80+13 a dose of the medication.
81+14 (c) If the conditions of this Act are satisfied, the child
82+15 may possess, self-administer, and use an epinephrine
83+16 auto-injector or inhaler at the camp or after-school care
84+17 program or at any camp-sponsored or program-sponsored
85+18 activity, event, or program.
86+19 (d) The recreational camp or after-school care program
87+20 must inform the parents or guardians of the child, in writing,
88+21 that the recreational camp or after-school care program and
89+22 its employees and agents are to incur no liability, as
90+23 applicable, except for willful and wanton conduct, as a result
91+24 of any injury arising from the self-administration of
92+25 medication to the child. The parents or guardians of the child
93+26 must sign a statement acknowledging that the recreational camp
14194
14295
143-advanced practice registered nurse.
144-(h) If after-school care program personnel administer an
145-undesignated epinephrine injection to a person and the
146-after-school care program personnel believe in good faith the
147-person is having an anaphylactic reaction or administer
148-undesignated asthma medication to a person and believe in good
149-faith the person is experiencing respiratory distress, then
150-the after-school care program and its employees and agents,
151-acting in accordance with standard protocols and the
152-prescription for the injection or medication, shall not incur
153-any liability or be subject to professional discipline, except
154-for willful and wanton conduct, as a result of any injury
155-arising from the use of the injection or medication,
156-notwithstanding whether notice was given to or authorization
157-was given by the child's parent or guardian or by the child's
158-physician, physician assistant, or advanced practice
159-registered nurse and notwithstanding the absence of the
160-parent's or guardian's signed statement acknowledging release
161-from liability.
162-(i) The changes made to this Section by this amendatory
163-Act of the 103rd General Assembly apply to actions filed on or
164-after the effective date of this amendatory Act of the 103rd
165-General Assembly.
166-(Source: P.A. 94-670, eff. 8-23-05.)
167-Section 99. Effective date. This Act takes effect upon
168-becoming law.
96+
97+
98+
99+ HB2949 Enrolled - 3 - LRB103 27415 DTM 53787 b
100+
101+
102+HB2949 Enrolled- 4 -LRB103 27415 DTM 53787 b HB2949 Enrolled - 4 - LRB103 27415 DTM 53787 b
103+ HB2949 Enrolled - 4 - LRB103 27415 DTM 53787 b
104+1 or after-school care program is to incur no liability, except
105+2 for willful and wanton conduct, as a result of any injury
106+3 arising from the self-administration of medication by the
107+4 child and that the parents or guardians must indemnify and
108+5 hold harmless the recreational camp or after-school care
109+6 program and its employees and agents, as applicable, against
110+7 any claims, except a claim based on willful and wanton
111+8 conduct, arising out of the self-administration of medication
112+9 by the child.
113+10 (e) After-school care program personnel who have completed
114+11 an anaphylaxis training program as identified under the
115+12 Epinephrine Injector Act may administer an undesignated
116+13 epinephrine injection to any child if the after-school care
117+14 program personnel believe in good faith that the child is
118+15 having an anaphylactic reaction while in the after-school care
119+16 program. After-school care program personnel may carry
120+17 undesignated epinephrine injectors on their person while in
121+18 the after-school care program.
122+19 (f) After-school care program personnel may administer
123+20 undesignated asthma medication to any child if the
124+21 after-school care program personnel believe in good faith that
125+22 the child is experiencing respiratory distress while in the
126+23 after-school care program. After-school care program personnel
127+24 may carry undesignated asthma medication on their person while
128+25 in the after-school care program.
129+26 (g) If after-school care program personnel are to
130+
131+
132+
133+
134+
135+ HB2949 Enrolled - 4 - LRB103 27415 DTM 53787 b
136+
137+
138+HB2949 Enrolled- 5 -LRB103 27415 DTM 53787 b HB2949 Enrolled - 5 - LRB103 27415 DTM 53787 b
139+ HB2949 Enrolled - 5 - LRB103 27415 DTM 53787 b
140+1 administer an undesignated epinephrine injection or an
141+2 undesignated asthma medication to a child, the after-school
142+3 care program personnel must inform the parents or guardians of
143+4 the child, in writing, that the after-school care program and
144+5 its employees and agents, acting in accordance with standard
145+6 protocols and the prescription for the injection or
146+7 medication, shall incur no liability, except for willful and
147+8 wanton conduct, as a result of any injury arising from the
148+9 administration of the injection or medication, notwithstanding
149+10 whether authorization was given by the child's parents or
150+11 guardians or by the child's physician, physician assistant, or
151+12 advanced practice registered nurse. A parent or guardian of
152+13 the child must sign a statement acknowledging that the
153+14 after-school care program and its employees and agents are to
154+15 incur no liability, except for willful and wanton conduct, as
155+16 a result of any injury arising from the administration of the
156+17 medication or injection, regardless of whether authorization
157+18 was given by a parent or guardian of the child or by the
158+19 child's physician, physician assistant, or advanced practice
159+20 registered nurse, and that the parent or guardian must also
160+21 indemnify and hold harmless the after-school care program and
161+22 its employees and agents against any claims, except a claim
162+23 based on willful and wanton conduct, arising out of the
163+24 administration of the medication or injection, regardless of
164+25 whether authorization was given by the child's parent or
165+26 guardian or by the child's physician, physician assistant, or
166+
167+
168+
169+
170+
171+ HB2949 Enrolled - 5 - LRB103 27415 DTM 53787 b
172+
173+
174+HB2949 Enrolled- 6 -LRB103 27415 DTM 53787 b HB2949 Enrolled - 6 - LRB103 27415 DTM 53787 b
175+ HB2949 Enrolled - 6 - LRB103 27415 DTM 53787 b
176+1 advanced practice registered nurse.
177+2 (h) If after-school care program personnel administer an
178+3 undesignated epinephrine injection to a person and the
179+4 after-school care program personnel believe in good faith the
180+5 person is having an anaphylactic reaction or administer
181+6 undesignated asthma medication to a person and believe in good
182+7 faith the person is experiencing respiratory distress, then
183+8 the after-school care program and its employees and agents,
184+9 acting in accordance with standard protocols and the
185+10 prescription for the injection or medication, shall not incur
186+11 any liability or be subject to professional discipline, except
187+12 for willful and wanton conduct, as a result of any injury
188+13 arising from the use of the injection or medication,
189+14 notwithstanding whether notice was given to or authorization
190+15 was given by the child's parent or guardian or by the child's
191+16 physician, physician assistant, or advanced practice
192+17 registered nurse and notwithstanding the absence of the
193+18 parent's or guardian's signed statement acknowledging release
194+19 from liability.
195+20 (i) The changes made to this Section by this amendatory
196+21 Act of the 103rd General Assembly apply to actions filed on or
197+22 after the effective date of this amendatory Act of the 103rd
198+23 General Assembly.
199+24 (Source: P.A. 94-670, eff. 8-23-05.)
200+25 Section 99. Effective date. This Act takes effect upon
201+26 becoming law.
202+
203+
204+
205+
206+
207+ HB2949 Enrolled - 6 - LRB103 27415 DTM 53787 b